JCHOR

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Index
Original Article
The role of initial sodium and globulin values in the prognosis prediction of patients diagnosed with colon cancer
Aims: Early prediction of prognosis in malignancies can help determine life expectancy and take necessary further measures accordingly. There is no consensus on using any biomarker in predicting prognosis in colon cancer cases. A study reported that the sodium/globulin ratio is a valuable biomarker in predicting the prognosis of gastric cancer. This study aimed to investigate the role of baseline sodium, globulin, and sodium/globulin ratio in the prediction of prognosis and survival in colon cancer cases.
Methods: The files of patients diagnosed with colon cancer who applied to Kırıkkale University Faculty of Medicine Medical Oncology Clinic between January 1, 2015, and December 31, 2020, were retrospectively analyzed. The relationship between the clinical and laboratory characteristics of the cases and their progression and survival were investigated.
Results: 140 patients diagnosed with colon cancer were included in the study (82 men, 58 women). The average age at diagnosis was 64.1±12.6 years, 99.3% of them were adenocarcinoma, and 32.9% of them were stage 4 cancers. It was determined that 42.1% of the patients died (average survival time 54.0±3.2 months), and progression developed in 18.6% during the study period. The average baseline sodium/globulin ratio was 51.10±8.70. No significant correlation was found between initial serum sodium level, globulin level, sodium/globulin ratio, survival time, and progression status (p>0.05). Baseline serum globulin level showed a weak negative correlation with both progression-free and overall survival time (r=-0.23, p<0.05 and r=-0.24, p<0.05, respectively), while the sodium/globulin ratio showed a weak positive correlation with progression-free survival time (r=0.26, p<0.01) and overall survival time (r=0.25, p<0.01). The ROC curve analysis determined that initial serum sodium and globulin levels and sodium/globulin ratio were not predictive of progression and survival at any cut-off point (p>0.05).
Conclusion: Although baseline serum sodium level, globulin level, and serum sodium/globulin ratio were weakly correlated with progression-free and overall survival time of patients diagnosed with colon cancer, they were not valuable in predicting progression and survival.


1. Xiao JB, Leng AM, Zhang YQ, Wen Z, He J, Ye GN. CUEDC2:multifunctional roles in carcinogenesis. Front Biosci (Landmark Ed).2019;24(5):935-946. doi:10.2741/4759
2. Gajendran M, Loganathan P, Jimenez G, et al. A comprehensivereview and update on ulcerative colitis. Dis Mon. 2019; 65(12):100851.doi:10.1016/j.disamonth.2019.02.004
3. Sokic-Milutinovic A. Appropriate management of attenuated familialadenomatous polyposis: report of a case and review of the literature.Dig Dis. 2019;37(5):400-405. doi:10.1159/000497207
4. Allen J, Sears CL. Impact of the gut microbiome on the genome andepigenome of colon epithelial cells: contributions to colorectal cancerdevelopment. Genome Med. 2019;11(1):11. doi:10.1186/s13073-019-0621-2
5. Snyder C, Hampel H. Hereditary colorectal cancer syndromes. SeminOncol Nurs. 2019;35(1):58-78. doi:10.1016/j.soncn.2018.12.011
6. C&eacute;lind J, Ohlsson C, Bygdell M, Nethander M, Kindblom JM.Childhood body mass index is associated with risk of adult coloncancer in men: an association modulated by pubertal change in bodymass index. Cancer Epidemiol Biomarkers Prev. 2019;28(5):974-979.doi:10.1158/1055-9965.EPI-18-1077
7. Pedersen JK, Rosholm JU, Ewertz M, Engholm G, Lindahl-Jacobsen R,Christensen K. Declining cancer incidence at the oldest ages: Hallmarkof aging or lower diagnostic activity?. J Geriatr Oncol. 2019;10(5):792-798. doi:10.1016/j.jgo.2019.02.001
8. Batool R, Jamal K, Sheroze MW, et al. Clinical features of colorectalcarcinoma at the Jinnah Postgraduate Medical Centre, Karachi,Pakistan: a cross-sectional study. J Med Res Health Sci. 2022;5(9):2203-2209. doi: 10.52845/JMRHS/2022-5-9-1
9. T.C. Sağlık Bakanlığı T&uuml;rkiye Halk Sağlığı Kurumu T&uuml;rkiye Kanserİstatistikleri, Ankara 2017. [Internet] https://hsgm.saglik.gov.tr/tr/kanser-istatistikleri. Erişim: 14.8.21.
10. Singh N, Baby D, Rajguru JP, Patil PB, Thakkannavar SS, PujariVB. Inflammation and cancer. Ann Afr Med. 2019;18(3):121-126.doi:10.4103/aam.aam_56_18
11. Tuomisto AE, M&auml;kinen MJ, V&auml;yrynen JP. Systemic inflammationin colorectal cancer: Underlying factors, effects, and prognosticsignificance. World J Gastroenterol. 2019;25(31):4383-4404. doi:10.3748/wjg.v25.i31.4383
12. Rosner MH, Dalkin AC. Electrolyte disorders associated with cancer.Adv Chronic Kidney Dis. 2014;21(1):7-17. doi:10.1053/j.ackd.2013.05.005
13. Doshi SM, Shah P, Lei X, Lahoti A, Salahudeen AK. Hyponatremia inhospitalized cancer patients and its impact on clinical outcomes. Am JKidney Dis. 2012;59(2):222-228. doi:10.1053/j.ajkd.2011.08.029
14. Zhang L, Wang Z, Xiao J, et al. Sodium to globulin ratio as aprognostic factor for patients with advanced gastric cancer. J Cancer.2020;11(24):7320-7328. doi:10.7150/jca.47314
15. Lopes G, Stern MC, Temin S, et al. Early detection for colorectalcancer: ASCO Resource-Stratified Guideline. J Glob Oncol. 2019;5:1-22.doi:10.1200/JGO.18.00213
16. Chen W, Xin S, Xu B. Value Research of NLR, PLR, and RDW inprognostic assessment of patients with colorectal cancer. J Healthc Eng.2022;2022:7971415. doi:10.1155/2022/7971415
17. Ulanja MB, Rishi M, Beutler BD, et al. Colon cancer sidedness,presentation, and survival at different stages. J Oncol. 2019;2019:4315032.doi:10.1155/2019/4315032
18. Wang L, Wilson SE, Stewart DB, Hollenbeak CS. Marital status andcolon cancer outcomes in US Surveillance, Epidemiology and EndResults registries: does marriage affect cancer survival by genderand stage?. Cancer Epidemiol. 2011;35(5):417-422. doi:10.1016/j.canep.2011.02.004
19. Chowdhury S, Mainwaring P, Zhang L, et al. Systematic review andmeta-analysis of correlation of progression-free survival-2 and overallsurvival in solid tumors. Front Oncol. 2020;10:1349. doi:10.3389/fonc.2020.01349
20. Peach G, Kim C, Zacharakis E, Purkayastha S, Ziprin P. Prognosticsignificance of circulating tumour cells following surgical resection ofcolorectal cancers: a systematic review. Br J Cancer. 2010;102(9):1327-1334. doi:10.1038/sj.bjc.6605651
21. Benitez Majano S, Di Girolamo C, Rachet B, et al. Surgical treatment and survival from colorectal cancer in Denmark, England, Norway,and Sweden: a population-based study. Lancet Oncol. 2019;20(1):74-87.doi:10.1016/S1470-2045(18)30646-6
22. Arhin ND, Shen C, Bailey CE, et al. Surgical resection and survivaloutcomes in metastatic young adult colorectal cancer patients. CancerMed. 2021;10(13):4269-4281. doi:10.1002/cam4.3940
23. Yu Z, Chen Z, Wu J, Li Z, Wu Y. Prognostic value of pretreatmentserum carbohydrate antigen 19-9 level in patients with colorectalcancer: A meta-analysis. PLoS One. 2017;12(11):e0188139. doi:10.1371/journal.pone.0188139
24. Stokkel LE, van Rossum HH, van de Kamp MW, et al. Clinical valueof preoperative serum tumor markers CEA, CA19-9, CA125, andCA15-3 in surgically treated urachal cancer. Urol Oncol. 2023;S1078-1439(23)00045-5. doi:10.1016/j.urolonc.2023.01.018
25. Basbug M, Arikanoglu Z, Bulbuller N, et al. Prognostic value ofpreoperative CEA and CA 19-9 levels in patients with colorectal cancer.Hepatogastroenterology. 2011;58(106):400-405.
26. Narita Y, Taniguchi H, Komori A, et al. CA19-9 level as a prognostic andpredictive factor of bevacizumab efficacy in metastatic colorectal cancerpatients undergoing oxaliplatin-based chemotherapy. Cancer ChemotherPharmacol. 2014;73(2):409-416. doi:10.1007/s00280-013-2367-7
27. Martini F, Guadagni F, Lenti L, et al. CA 19-9 monosialogangliosidecontent of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation. Anticancer Res. 2000;20(3A):1609-1614.
28. Sun DW, An L, Lv GY. Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: anupdated meta-analysis. World J Surg Oncol. 2020;18(1):9. doi:10.1186/s12957-020-1786-2
29. Hara K, Aoyama T, Yamada T, et al. The prognostic value of theperioperative systemic inflammation score for patients with advancedgastric cancer. Anticancer Res. 2020;40(3):1503-1512. doi:10.21873/anticanres.14095
30. Xu J, Chen X, Wang X, et al. Preoperative hyponatremia andhypocalcemia predict poor prognosis in elderly gastric cancer patients.Cancer Manag Res. 2019;11:8765-8780. doi:10.2147/CMAR.S211603
31. House CD, Vaske CJ, Schwartz AM, et al. Voltage-gated Na+ channelSCN5A is a key regulator of a gene transcriptional network thatcontrols colon cancer invasion. Cancer Res. 2010;70(17):6957-6967.doi:10.1158/0008-5472.CAN-10-1169
32. Scheipner L, Smolle MA, Barth D, et al. The AST/ALT ratio is anindependent prognostic marker for disease-free survival in stage IIand III colorectal carcinoma. Anticancer Res. 2021;41(1):429-436.doi:10.21873/anticanres.14792
33. Jiang Z, Li C, Zhao Z, et al. Abnormal liver function induced by space-occupying lesions is associated with unfavorable oncologic outcomein patients with colorectal cancer liver metastases. Biomed Res Int.2018;2018:9321270. doi:10.1155/2018/9321270
34. Park JS, Park HC, Choi DH, et al. Prognostic and predictive value of livervolume in colorectal cancer patients with unresectable liver metastases.Radiat Oncol J. 2014;32(2):77-83. doi:10.3857/roj.2014.32.2.77
Volume 1, Issue 2, 2023
Page : 24-30
_Footer